Glenmark Pharmaceuticals Inc., USA (Glenmark) has received final approval by the United States Food & Drug Administration ...

Telangana: Drugs Control Administration, Telangana, has seized Spurious Drugs (Counterfeit Versions) 'Montek-LC' Tablets ...

The rejected bids are for papaverine hydrochloride 60mg in 2ml capsules. The first offer was for Rs. 73,000 per ampule. The TEC rejected it and recommended for Yaden to re-tender. It did so in May ...

Developed by Ireland-based BrePco Biopharma, Neoatricon is the first paediatric-strength dopamine hydrochloride infusion for ...

Dublin: BrePco Biopharma Limited (BPCO) that develops products for the unique needs of paediatric patients and Piramal ...

Piramal Critical Care, a part of Piramal Pharma, and Ireland-based BrePco Biopharma have received marketing approval from the ...

Piramal Critical Care and BrePco Biopharma received UK approval for Neoatricon, a paediatric Dopamine Hydrochloride solution.

Eric J. Fues and Kyle W. Howarth of Finnegan address the on-sale bar in patent law, with a focus on how pre-filing sales of ...

The Food and Drug Administration (FDA) has expanded the list of medicines for non-communicable diseases (NCDs) exempted from ...

1Glenmark's Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% (OTC) is only marketed for the indications listed in Glenmark's approved drug facts label. 2 This product is not manufactured or ...

Piramal Critical Care has reserved commercialisation rights for the EU, UK, and Norway and will look after Neoatricon in ...

Glenmark Pharma's stock rose after it said Glenmark Pharmaceuticals Inc., USA, has received final approval from the USFDA for ...